A detailed history of Nova Wealth Management, Inc. transactions in Nektar Therapeutics stock. As of the latest transaction made, Nova Wealth Management, Inc. holds 10 shares of NKTR stock, worth $247. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Holding current value
$247
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

BUY
$0.49 - $29.68 $4 - $296
10 New
10 $258,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $4.65B
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Nova Wealth Management, Inc. Portfolio

Follow Nova Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nova Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nova Wealth Management, Inc. with notifications on news.